Free to use. No sign-up needed.

How can I help you sell?

Watch the 2-min demo Like ChatGPT married your dream sales app

The GTM App
For Founders

Ask Tnuki anything. Get an action-oriented table of verified prospects, timed buying signals, and customized outbound for your approval. Scaling to your next 50 customers has never been faster.

Get free prospects Free. No signup, no credit card.
Tnuki mascot Clover
Decorative rocks
Decorative vine

For startups that need to scale

The fastest path to
your next 50 customers

1

One simple chat

Start with a single sentence. Tnuki asks a couple of quick questions to zero in on your ideal customer — no filters, no database setup.

2

Get qualified prospects in seconds

Tnuki searches databases and the web, finds matching people and companies, and verifies emails and phone numbers, all automatically.

3

Every morning: top prospects are sent to you

Tnuki reads 1,000+ signal sources while you sleep. It sends you only the most relevant, signal-based prospects. Your customer growth engine never stops running.

tnuki.com
CA Biopharma Buyers
I sell spatial biology instruments
Researching spatial biology... Gathering targeting details...
Which buyers should I target first?
Core leaders Principal investigators Pathology leaders Translational research
Or type your own response...
I sell spatial biology instruments
Q: Which buyers should I target?
Translational research leads
Q: What company segment?
Top 20 biopharma in California
B2B database Web search Enriched 26
Found 26 translational leads across top California biopharma.
Message Tnuki... Send
#CompanyPersonEmail Draft
Your prospects will appear here
#CompanyPersonEmail Draft
1
Genentech
Genentech
South San Francisco, CA
10,000+
Laura Whitfield
Laura Whitfield
VP Translational Med
l.whitfield@gene.com
Reveal Phone
Spatial biology for trial readouts
Hi Laura — Noticed you're leading translational medicine at Genentech. Teams tying response back to tumor microenvironment state often struggle with spatial resolution from FFPE...
2
Amgen
Amgen
Thousand Oaks, CA
↗ Growing
James Nakamura
James Nakamura
Dir. Biomarkers
j.nakamura@amgen.com
Reveal Phone
Translational biomarkers at Amgen
Hi James — When taking a discovery biomarker into the clinic, the debate often comes down to which cells are driving the signal...
3
Pfizer
Pfizer
San Diego, CA
10,000+
Priya Malhotra
Priya Malhotra
Clinical Assay Lead
p.malhotra@pfizer.com
(858) 555-0193
Clinical assay workflows at Pfizer
Hi Priya — With Pfizer's expanded oncology pipeline, curious if your clinical assay team is seeing demand for higher-plex spatial...
4
Gilead
Gilead
Foster City, CA
10,000+
Sofia Reyes
Sofia Reyes
Dir. Clinical Biomarkers
s.reyes@gilead.com
Reveal Phone
Biomarker validation at Gilead
Hi Sofia — Saw Gilead's recent press release on the Phase IIb study. Spatial profiling is becoming critical for biomarker validation in...
5
BMS
BMS
San Diego, CA
↗ Growing
Rachel Kim
Rachel Kim
Dir. Companion Dx
r.kim@bms.com
(619) 555-0247
Companion dx spatial workflows
Hi Rachel — With BMS expanding the oncology biomarker budget, curious whether you're seeing demand for higher-plex spatial...
6
Regeneron
Regeneron
Tarrytown, NY
10,000+
Alex Torres
Alex Torres
Head of Translational Sci
a.torres@regeneron.com
Reveal Phone
Spatial transcriptomics at Regeneron
Hi Alex — Congrats on the recent expansion of Regeneron's translational sciences group. As you scale spatial profiling across...
6:00 AM

Today's Plays

Spatial Biology · US West Pharma & Biotech

726 stories analyzed overnight

FRI, APR 10

5 plays

+ 11 to know about

Reach out now
Review & send →
Jeff Tanaka To: Jeff Tanaka, Dir. Translational Science, Sidewinder
“I work with several ADC-stage biotechs and one thing that keeps coming up is how critical it is to show clean co-expression data on the target…”
What triggered this
Sidewinder Therapeutics raises $137M Series B to push bispecific ADC pipeline toward IND
Apr 10 — Oversubscribed (Frazier + Novartis) backs a 3-program bispecific ADC pipeline led by SWT012. SEC filing · BioPharma Dive
Reach out now
Review & send →
Priya Varma To: Priya Varma, Dir. Applications Development, Genentech
“Saw the label expansion news — curious how the team is thinking about scaling spatial IHC for companion Dx workflows as demand picks up…”
What triggered this
Genentech secures FDA label expansion for flagship oncology drug
Apr 9 — Expanded indication will pressure companion-Dx volume; three senior Dx hires posted this month confirm staff-up. FDA label update · LinkedIn hires
Good to know
Gilead to acquire ADC specialist Tubulis for up to $5B
Apr 8 — Validates ADC investment; combined oncology portfolio opens cross-sell window in 60-90 days. Gilead press · Endpoints News
C4 Therapeutics × Roche expand DAC collaboration with $20M upfront
Apr 7 — TPD meets ADCs: Roche's DAC expansion is a near-term driver of target-expression and tissue selectivity studies. C4 press · BioSpace
Decorative pot with clovers

Try it live

Explore an actual Tnuki table.

Ask your own follow-ups and explore how Tnuki works.

Live Tnuki table with verified prospects, buying signals, and personalized email drafts
Try it live Click anywhere to open this thread in a new tab.

Pricing & comparison

Your ideal pipeline, for free.

Start instantly for free. No sign-up, no credit card.

Tnuki Apollo Clay
Data freshness Real-time, live web Cached DB On-demand via providers
Coverage 1B+ people, 100M+ companies ~250M people Requires other providers
Setup time Minutes Weeks Weeks
Usable free tier Access for free
Fully conversational (chat-first)
AI email drafts Manual setup
Trigger-grounded personalization Manual setup

Competitor pricing and estimates reflect public pricing pages and vendor-disclosed figures.

FAQ

Frequently asked questions

The latest news about AI-powered sales prospecting. (Last updated May 2026)

What is Tnuki?
Tnuki is the GTM app for founders — like ChatGPT married your dream sales app. You ask Tnuki anything in natural language, and it returns a table of hundreds or thousands of prospects with timed buying signals (funding rounds, exec hires, regulatory filings, LinkedIn posts), customer research, competitive awareness, and outbound emails drafted in your voice — for your approval. Unlike autonomous AI SDRs (11x.ai, Artisan), Tnuki keeps the founder in the loop on every send. Free to start, no signup, no credit card.
What is an AI sales prospecting tool?
An AI sales prospecting tool uses artificial intelligence to automate finding, researching, and reaching out to prospective customers. Unlike traditional sales prospecting tools (Apollo, ZoomInfo, Clay) that require building filters or workflows in a database UI, AI sales prospecting tools like Tnuki run autonomous agents that monitor your target market for buying triggers, verify contacts in real-time, and draft personalized outreach grounded in actual events. The result: your daily plays with priority accounts, the trigger behind each one, verified contacts, and ready-to-send drafts.
How is Tnuki different from Clay, Apollo, or ZoomInfo?
Clay, Apollo, and ZoomInfo are database-first tools that require you to build filters, configure workflows, and stitch together multiple products. Tnuki is conversation-first: you describe what you need in natural language, and the AI handles prospecting, enrichment, and email drafting in one flow. Your ICP reasoning carries through to every email, producing genuine personalization instead of template filling. Plus, Tnuki delivers your daily plays to your inbox — a daily playbook with new prospects, buying signals, and personalized outreach ready to send. No setup, no waterfall configuration. Just results.
Can I find leads for a very specific or niche ICP?
Absolutely. Tnuki excels at hyper-specific targeting because it uses AI search rather than rigid database filters. You can describe ICPs like "compliance officers at Series A fintechs in the northeast" or "DevOps leads at companies that just migrated to Kubernetes." Specificity that would take hours of manual filtering in LinkedIn Sales Navigator or Cognism. Tnuki translates your natural language into multi-source searches and returns qualified matches.
What are Today's Plays?
Today's Plays are recurring, AI-generated email digests that monitor your market and prospect lists. Tnuki's agents scan news, LinkedIn posts, X/Twitter activity, job postings, SEC filings, and funding databases, then send you a concise summary with personalized outreach ready to send. Think of it as a personal research analyst that never sleeps, delivering actionable intelligence straight to your inbox — daily, weekly, or on your preferred cadence.
How is Tnuki different from AI SDR tools like 11x.ai, Artisan, or Regie.ai?
AI SDR tools like 11x.ai ($5,000+/month), Artisan, and Regie.ai position as "replace your SDR." Tnuki positions as "make your SDR superhuman." AI SDRs are black boxes: you give them an ICP and hope for the best. Tnuki's conversational interface gives your team full transparency and control: they see every search, every enrichment, every draft. You get AI-powered speed without giving up human judgment, at a fraction of the cost.
Is Tnuki free to use?
Yes. Tnuki has a free tier — you can use the Tnuki chat to find prospects, verify contacts, and draft outreach, plus receive your daily plays at a regular cadence. No signup, no credit card required. Paid plans (with higher-volume usage and more frequent plays) will be announced separately.
Is Tnuki good for founder-led sales or small teams?
Tnuki was designed for it. Founders and small teams can't afford $30K+ ZoomInfo contracts or dedicate hours to building Clay workflows. Tnuki replaces 3–5 separate sales tools with a single conversation: describe your ICP, get enriched prospects, draft outreach, and set up your daily plays — all in minutes. The free plan includes 100 prospects per month and 5 daily plays. No sales call required, no CRM integration needed, no learning curve beyond typing what you need.
What is signal-based selling, and how is it different from traditional cold outbound?
Signal-based selling (also called intent-based selling or trigger-event selling) means timing your outreach to real buying signals — funding rounds, executive hires, regulatory filings, LinkedIn posts about specific operational pain — instead of sending identical messaging to a static list. The premise: your buyers leave signals every day that they're in-market, but most reps don't have time to read them. Tnuki's Signal Agent monitors 1,000+ public sources 24/7 and turns the signals worth acting on into ranked plays with verified contacts and outreach drafted around the trigger. Industry data suggests signal-grounded outreach typically delivers 2-10× the reply rates of cold outbound, because the message references something the prospect actually cares about today.
What is a GTM app for founders?
A GTM (go-to-market) app for founders is a single tool that handles the day-to-day work of prospecting, contact verification, and outreach drafting — without the assumption that you have an SDR team or a $32K ZoomInfo budget. The founder running GTM doesn't have time to glue together five tools or build Clay enrichment waterfalls; they need to describe their ICP, get qualified prospects, and have outreach ready before their first standup. Tnuki is the GTM app for founders: a conversational AI that monitors 1,000+ sources for buying signals, surfaces today's best prospects, and drafts your outreach in your voice — every morning.

We guarantee you'll find ideal prospects in <60 seconds.

Start building your customer growth engine now.

Or talk to a human →